Evidence map›Paper›PMID 25755036›Full record

Trial reportAnnals of family medicine2015

Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.

Justin B Echouffo-Tcheugui, Rebecca K Simmons, A Toby Prevost, Kate M Williams, Ann-Louise Kinmonth, Nicholas J Wareham, Simon J Griffin

Abstract readPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Annals of family medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Screening for type 2 diabetes mellitus.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Improving Diabetes Screening in the Primary Care Clinic.Joint Commission journal on quality and patient safety · 2023
    Article
  6. Article
  7. Article
  8. Observational
  9. Screening for Diabetes and Prediabetes.Endocrinology and metabolism clinics of North America · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Justin B Echouffo-TcheuguiMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Rebecca K SimmonsMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
A Toby PrevostDepartment of Primary Care and Public Health Sciences, School of Medicine, King's College London, London, United Kingdom.
Kate M WilliamsThe Primary Care Unit, Cambridge Institute of Public Health, Cambridge, United Kingdom.
Ann-Louise KinmonthThe Primary Care Unit, Cambridge Institute of Public Health, Cambridge, United Kingdom.
Nicholas J WarehamMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Simon J GriffinMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom The Primary Care Unit, Cambridge Institute of Public Health, Cambridge, United Kingdom sjg49@medschl.cam.ac.uk.

Funding

Department of Health 08/116/300Department of Health RP-PG-0606-1259Medical Research Council G0001164Medical Research Council MC_U106179471Medical Research Council MC_U106179474Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12015/4
6 · The paper itself

Abstract

purposeThere is limited trial evidence concerning the long-term effects of screening for type 2 diabetes on population morbidity. We examined the effect of a population-based diabetes screening program on cardiovascular morbidity, self-rated health, and health-related behaviors.

methodsWe conducted a pragmatic, parallel-group, cluster-randomized controlled trial of diabetes screening (the ADDITION-Cambridge study) including 18,875 individuals aged 40 to 69 years at high risk of diabetes in 32 general practices in eastern England (27 practices randomly allocated to screening, 5 to no-screening for control). Of those eligible for screening, 466 (2.9%) were diagnosed with diabetes. Seven years after randomization, a random sample of patients was sent a postal questionnaire: 15% from the screening group (including diabetes screening visit attenders and non-attenders) and 40% from the no-screening control group. Self-reported cardiovascular morbidity, self-rated health (using the SF-8 Health Survey and EQ-5D instrument), and health behaviors were compared between trial groups using an intention-to-screen analysis.

resultsOf the 3,286 questionnaires mailed out, 1,995 (61%) were returned, with 1,945 included in the analysis (screening: 1,373; control: 572). At 7 years, there were no significant differences between the screening and control groups in the proportion of participants reporting heart attack or stroke (OR = 0.90, 95% CI, 0.71-1.15); SF-8 physical health summary score as an indicator of self-rated health status (β -0.33, 95% CI, -1.80 to 1.14); EQ-5D visual analogue score (β: 0.80, 95% CI, -1.28 to 2.87); total physical activity (β 0.50, 95% CI, -4.08 to 5.07); current smoking (OR 0.97, 95% CI, 0.72 to 1.32); and alcohol consumption (β 0.14, 95% CI, -1.07 to 1.35).

conclusionsInvitation to screening for type 2 diabetes appears to have limited impact on population levels of cardiovascular morbidity, self-rated health status, and health behavior after 7 years.

Indexed as

Health StatusMotor ActivityAdultAgedAlcohol DrinkingCardiovascular DiseasesDiabetes Mellitus, Type 2EnglandFemaleHealth BehaviorHumansLongitudinal StudiesMaleMass ScreeningMiddle AgedMyocardial InfarctionADDITION-Cambridgecardiovascular morbiditydiabeteshealth behaviorscreeningself-rated health

Identifiers

PMID25755036
PMCPMC4369602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.